A carregar...
Prognostic Clinical and Radiographic Biomarkers for BRAF‐Targeted Therapy in Advanced Melanoma
Agents blocking BRAF and MEK produce robust responses in patients with BRAF (V600)‐mutated melanoma; however, more accurate clinical biomarkers are needed to predict prognosis. To explore this question, we retrospectively studied 158 patients with BRAF‐mutated melanoma treated with BRAF with or with...
Na minha lista:
| Publicado no: | Oncologist |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7873326/ https://ncbi.nlm.nih.gov/pubmed/33044751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13562 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|